Tivic Health Registers 400K Shares for Resale Linked to Statera Biopharma License Agreement

Tivic Health Systems is registering 400,044 shares of common stock for resale by selling stockholders, tied to the Exclusive License Agreement with Statera Biopharma. The agreement was signed on February 11 and amended on June 18, 2025. The stock issuance is a result of the agreement between the two companies.

Tivic Health Systems (NASDAQ: TIVC) has registered 400,044 shares of common stock for potential resale by selling stockholders, according to a recent SEC filing. The stock issuance is tied to an Exclusive License Agreement with Statera Biopharma, which was signed on February 11 and amended on June 18, 2025. The agreement involves the sale of shares in exchange for the license deal [1].

The registration statement, filed on August 8, 2025, details the terms of the offering. The shares being offered include 111,339 shares issued under Securities Purchase Agreements dated February 11 and March 31, 2025, and 51,504 shares issued on July 3, 2025, upon conversion of Series A Non-Voting Convertible Preferred Stock. Additionally, 237,201 shares are issuable upon conversion of additional Series A Preferred Stock [2].

Tivic Health Systems has agreed to pay certain expenses related to the registration of the offer and sale of its common stock. The company will not receive any proceeds from the sale of the shares by the selling stockholders. The selling stockholders will bear all commissions, discounts, concessions, and other selling expenses.

The registration statement also outlines the risks associated with investing in Tivic Health Systems' common stock. Investors should carefully read the "Risk Factors" section of the prospectus before making investment decisions.

The company's common stock is listed on the Nasdaq Capital Market under the symbol "TIVC." As of August 5, 2025, the closing price of the common stock was $3.38 per share.

References:
[1] https://seekingalpha.com/news/4482891-tivic-health-registers-400k-shares-for-resale-linked-to-statera-license-deal
[2] https://www.stocktitan.net/sec-filings/TIVC/s-3-tivic-health-systems-inc-shelf-registration-statement-3b9c2b1defcb.html